Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Roche Holding AG Participation (ROG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
220.10 -1.40    -0.63%
11:34:00 - Closed. Currency in CHF ( Disclaimer )
Type:  Equity
Market:  Switzerland
ISIN:  CH0012032048 
VALOR:  1203204
  • Volume: 1,099,673
  • Bid/Ask: 220.10 / 220.20
  • Day's Range: 218.70 - 222.20
Roche Holding Participation 220.10 -1.40 -0.63%

ROG Cash Flow Statement

 
Featured here, the Cash Flow Statement for Roche Holding AG Participation, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line 2180.5 2180.5 3568.5 3568.5
Cash From Operating Activities 4098.5 4098.5 3949 3949
Depreciation/Depletion 679.5 679.5 694.5 694.5
Amortization 177.5 177.5 180.5 180.5
Deferred Taxes -304.5 -304.5 -250.5 -250.5
Non-Cash Items 705 714.5 401.5 401.5
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 1025 1025 785 785
Cash Interest Paid 201 201 184 184
Changes in Working Capital 348.5 348.5 -902 -902
Cash From Investing Activities -5080.5 -5080.5 -241 -241
Capital Expenditures -1001 -1001 -870 -870
Other Investing Cash Flow Items, Total -4079.5 -4079.5 629 629
Cash From Financing Activities 2027 2027 -4146.5 -4146.5
Financing Cash Flow Items -261 -261 -214.5 -214.5
Total Cash Dividends Paid - - -3795 -3795
Issuance (Retirement) of Stock, Net -255.5 -255.5 -316.5 -316.5
Issuance (Retirement) of Debt, Net 2543.5 2543.5 179.5 179.5
Foreign Exchange Effects -52 -52 -69.5 -69.5
Net Change in Cash 828 828 -635.5 -635.5
Beginning Cash Balance 4548 4548 4355.5 4355.5
Ending Cash Balance 5376 5376 3720 3720
Free Cash Flow 1836 1266 3287.69 2214.69
Free Cash Flow Growth 45.02 -61.49 48.45 -9.02
Free Cash Flow Yield 1.41 1.38 1.36 1.42
* In Millions of CHF (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ROG Comments

Write your thoughts about Roche Holding AG Participation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mikel ibanez
Mikel ibanez Dec 04, 2023 6:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
18 per and 4% dividend starts looking good. Long hold and nice life investment in one of Europe best companies in a non hype sector
BOXING HUANG
BOXING HUANG Oct 19, 2023 6:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happened today?
Giancarlo Velotti
Giancarlo Velotti Jul 13, 2023 3:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It is a buy at 266
taja maja
taja maja Jan 26, 2023 2:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When ist best time to buy?
Scott Goldie
Scott Goldie Jan 17, 2023 5:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SP suffering since May 2022 due to decline in COVID vaccines.
Jonah Garber
Jonah Garber Jul 24, 2022 12:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
macd indicators showing a nice jump coming, keeping my fingers crossed during these dark times
BOXING HUANG
BOXING HUANG May 11, 2022 4:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happened today?
Tvynis Jutvynis
Tvynis Jutvynis May 11, 2022 4:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The SKYSCRAPER-01 study evaluating tiragolumab plus Tecentriq did not meet its co-primary endpoint of progression-free survival
Tvynis Jutvynis
Tvynis Jutvynis May 11, 2022 4:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Today only this info about Roche
Sherlyn Jones
Sherlyn Jones Apr 22, 2021 6:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
Financial Advisors
Financial Advisors Apr 22, 2021 6:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hello to Marinopoulos Pharma company .!
José Spescha
José Spescha Mar 18, 2021 4:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Trades ex dividend!!
Victor Garcia
Victor Garcia Feb 01, 2021 2:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Currently near to Fibo 61.8 levels, a great company to buy IMO.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email